Signadori Bio
Healthcare
HQ: Paris, France
Investors: 1
Develops therapeutics targeting gene regulation pathways
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Sofinnova Partners | Current | - | - | Website |
Develops therapeutics targeting gene regulation pathways
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Sofinnova Partners | Current | - | - | Website |